Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for 10x Genomics (TXG : NSDQ)

• Company Description    10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. Number of Employees: 410

• Price / Volume Information    Yesterday's Closing Price: $13.01 Daily Weekly Monthly 20 Day Moving Average: 4,184,147 shares Shares Outstanding: 123.13 (millions) Market Capitalization: $1,601.97 (millions) Beta: 2.03 52 Week High: $24.76 52 Week Low: $6.78 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 38.11% 31.97% 12 Week 62.42% 38.73% Year To Date -9.40% -15.14%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 6230 STONERIDGE MALL ROAD - PLEASANTON,CA 94588 USA ph: 925-401-7300 fax: - investors@10xgenomics.com http://www.10xgenomics.com

• General Corporate Information    Officers Serge Saxonov - Chief Executive Officer and Director John R. Stuelpnagel - Chairman Benjamin J. Hindson - President Adam S. Taich - Chief Financial Officer Sridhar Kosaraju - Director Peer Information 10x Genomics (HLIS) 10x Genomics (AZTA) 10x Genomics (APYI) 10x Genomics (RNVA) 10x Genomics (HMSY) 10x Genomics (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 88025U109 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/14/25 Share - Related Items Shares Outstanding: 123.13 Most Recent Split Date: (:1) Beta: 2.03 Market Capitalization: $1,601.97 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.27 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.20 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 25.05% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/14/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.25 Price/Cash Flow: - Price / Sales: 2.56 EPS Growth vs. Year Ago Period: 28.00% vs. Previous Quarter: 10.00% Sales Growth vs. Year Ago Period: 9.84% vs. Previous Quarter: -6.14% ROE 06/30/25 - - 03/31/25 - -23.22 12/31/24 - -25.40 ROA 06/30/25 - - 03/31/25 - -18.02 12/31/24 - -19.69 Current Ratio 06/30/25 - - 03/31/25 - 5.37 12/31/24 - 4.97 Quick Ratio 06/30/25 - - 03/31/25 - 4.68 12/31/24 - 4.26 Operating Margin 06/30/25 - - 03/31/25 - -26.61 12/31/24 - -29.90 Net Margin 06/30/25 - - 03/31/25 - -25.14 12/31/24 - -29.90 Pre-Tax Margin 06/30/25 - - 03/31/25 - -24.56 12/31/24 - -29.09 Book Value 06/30/25 - - 03/31/25 - 5.78 12/31/24 - 5.81 Inventory Turnover 06/30/25 - - 03/31/25 - 2.32 12/31/24 - 2.25 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©